Welcome to This Week in Ophthalmology. This week we're covering 9 notable papers spanning the expanding role of artificial intelligence in diagnostics, new strategies in glaucoma risk assessment, and evolving therapeutics for the anterior and posterior segment. Let's dive in.

This week's papers:

1. AI-based oculomics for trajectory-driven risk stratification of pathologic myopia in paediatric high myopia. — The British journal of ophthalmology 2026
2. Gildeuretinol Acetate vs Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The SAGA Randomized Clinical Trial. — Ophthalmology. Retina 2026
3. Risk-Stratified Monitoring of Open Angle Glaucoma Suspects Based on Diagnostic Conversion Risk. — American journal of ophthalmology 2026
4. Large Language Model Authorship in Ophthalmic Publications. — Ophthalmology 2026
5. An Eye Bank and Ex Vivo Pilot Study of Shelf-Stable Corneal Plugs for Perforation Repair. — Cornea 2026
6. Smartphone-Based Proactive Self-Screening for Ocular Surface Malignancies: A Nonrandomized Clinical Trial. — JAMA ophthalmology 2026
7. Very Preterm Infant Retinal Microanatomy at 36 Weeks' Postmenstrual Age and 2-Year Neurodevelopment. — JAMA ophthalmology 2026
8. RANKL Inhibition and the Risk of Ocular Hypertension and Primary Open-Angle Glaucoma. — Investigative ophthalmology & visual science 2026
9. Stromal Transplantation and corneal-sparing techniques in ectatic diseases. — Progress in retinal and eye research 2026

Listen at AudioScholar